Tag: Asundexian
Asundexian development canceled: A flop that costs Bayer billions – Economy
The hope at Bayer was great, but now the disappointment is even more so. The flop of an important new drug in development weighed heavily on the shares of the…
Study of the drug Asundexian stopped: Bayer shares crash
As of: November 20, 2023 3:29 p.m The drug Asundexian was considered one of the most important developed by the pharmaceutical company Bayer. Now it is proving to be less…
Bayer shares double-digit lower: Bayer suffers billion-dollar glyphosate defeat in the USA – studies halted for hopefuls Asundexian
A US jury has sentenced the pharmaceutical and agricultural company Bayer to pay more than 1.5 billion US dollars in a glyphosate trial. Three former users of the weed killer…
Bayer share: Bayer suffers billion-dollar glyphosate defeat in the USA – study stop for hopefuls Asundexian November 20, 2023
A US jury has sentenced the pharmaceutical and agricultural company Bayer to pay more than 1.5 billion US dollars in a glyphosate trial. Three former users of the weed killer…